SUMMARY Thirteen patients with proven Q fever endocarditis and three additional patients with probable endocarditis are reviewed. The most helpful diagnostic test is the demonstration of a high complement fixing antibody titre to Phase I antigen of Coxiella burneti.
Q FEVER was originally described by Derrick in 1937 .1 The diagnosis is made by an increasing complement fixing antibody titre to the antigens of Coxiella burneti (C. burneti). These antibody titres are measured against Phase I and Phase 2 antigens. During the acute infection the rising antibody titre is to the Phase 2 antigen, whereas elevated antibody titre to Phase 1 antigen suggests past persistent infection;2 high titres are found in chronic infections, including Q fever endocarditis. 3 The ultimate diagnosis of Q fever endocarditis is based on identification of the organism in the affected valve tissue removed at autopsy or operation. Laboratory animals inoculated with such tissue demonstrate a rising antibody titre and C. burneti is present in their tissues.
Cases of Q fever must be reported to the Health Department in Queensland. All diagnostic blood tests are performed in the State Health Laboratory so that it is possible to follow all proven cases. This communication surveys Q fever endocarditis in Queensland from 1959 to 1974.
Clinical History
Twenty-one patients with Q fever and cardiac murmurs were reviewed. Thirteen patients had proven Q fever endocarditis, the organism being identified in the laboratory. Three additional patients had probable endocarditis with symptoms and signs of infective endocarditis, negative blood cultures, and high or rising titres to Phase 1 antigen. Of these, one patient was considered to have been cured prior to his death from uremia (case 10) and one died but no autopsy was done (case 5). The third (case 6) had five years of tetracycline therapy with apparent clinical cure prior to operation for residual valve damage. Only the sixteen patients with Q fever endocarditis are reported in this paper.
The clinical features of these sixteen patients are summarized in 
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Evidence is presented that the infection may be controlled by prolonged tetracycline therapy and that this is accompanied by a falling antibody titre to Phase 1 antigen. Valve replacement is undertaken only for symptomatic and hemodynamic indications. The combined tetracycline therapy and valve replacement have produced a fall in titres with eradication of infection and palliation of the cardiac disability in all patients followed for long periods.
fever, rigors, malaise, splenomegaly, painful emboli in hands and feet, and heart failure one year earlier. Three months before admission he had a transient left hemiparesis. Although a meat worker for 14 years, he had no definite history of Q fever. On examination he had aortic stenosis and incompetence (AS, Al) and a mycotic aneurysm of the right posterior tibial artery ( fig. 1 ).
His hemoglobin was 11.4 g/100 ml, C. reactive protein positive, serum protein 8.1 g/100 ml with 3.27 g/100 ml gamma globulin and complement fixing antibody titres greater than 1:512 to Phase 1 antigen.
He was given a prolonged course of tetracycline. On March 4, 1969 the aortic valve was removed and a calf heterograft valve was inserted. The fused bicuspid valve was disrupted around the whole of the attachment of the noncoronary leaflet and the adjacent anterior commissure, the valve tissue being like a bowstring across the aortic orifice. Some necrotic tissue was present with a large anterior commissure aneurysm (3.5 X 2.5 cm) projecting into the ventricular septum. C. burneti was not found in the smears, but grew in inoculated mice. Repeat angiogram ten days postoperatively showed the posterior tibial aneurysm had disappeared ( fig. 2) .
The heterograft valve later developed moderate incompetence and was replaced by a ring-supported fascia lata autograft in 1971. At reoperation no macroscopic or microscopic evidence of persisting Q fever infection was present. Incompetence was due to a tear in one of the heterograft valve cusps. The aneurysm had completely healed. The patient is now asymptomatic and the valve remains competent. It is considered that this man has been cured of Q fever endocarditis. Figure 3 shows the changing C.F. antibody titre to Phase I antigen.
Case 10 W.K., 64 years old, originally a butcher in Scotland, was first seen in 1963. He was admitted because of pain and swelling of the right calf and was found to have finger clubbing, anemia and Al.
The hemoglobin was 8.7 g/100 ml, erythrocyte sedimentation rate (ESR) 82 mm/hr, urine showed occasional red cells and gamma globulin was increased. The C.F. antibody titre to Phase 1 antigen was 1:1024.
He was treated with pyrrolidino-methyl-tetracycline (Reverin) 275 The longest "proven" interval between the original attack of Q fever and the clinical onset of Q fever endocarditis was seven years. This patient lived for a further eight years (and died by suicide) and his cardiac signs were not worsening at the time of his death (case 8).
It is probable that others had their initial Q fever 20 years (case 16), 14 years (case 2), 15 years (case 13), and 11 years (case 9) prior to their clinical presentation with Q fever endocarditis, but these times are based only on histories given by the patients.
Several of the other patients gave brief histories, but in some the initial history of "Q fever" was clearly the symptomatic onset of their Q fever endocarditis. However, both the initial attack of Q fever and the onset of Q fever endocarditis evidently may occur many years before clinically serious valve damage from the endocarditis occurs; hence, it is one of the most indolent forms of infective endocarditis. Diagnostic features often quoted for Q fever endocarditis include: male patients with aortic valve disease4 usually with anemia and a raised ESR5 and typically with a rise in the gamma globulin level. Grist5 also states that the white cell count may be low or normal and that albuminuria may often be present without red cells in the urine. Robson In our own 16 patients, 15 had some form of aortic valve disease, two had associated aortic and mitral lesions and only one had isolated mitral stenosis. One patient (case 14)
had tricuspid as well as aortic valve involvement. All were males, and 11 were meat industry workers or farmers. Ten had a raised ESR at some time in their illness, but contrary to Grist's findings, only one ever had hemoglobin less than 11 g/100 ml and this patient died of uremia and pulmonary thromboembolism.
Gamma globulin was increased in eight of the nine patients in whom it was measured. The white cell count in the blood was over 10,000/mm3 in only two patients. Fever was rarely present and only three of our patients had emboli from their valves. The patient who developed a mycotic aneurysm (shown radiographically and disappearing after treatment) had the first such lesion to be described in Q fever endocarditis (case 3).
In this series, as in that of Robson and Shimmin,6 anemia, leukocytosis, hematuria and emboli were uncommon. The most useful laboratory finding would appear to be increased gamma globulin, present in most cases tested for it in our experience. Other tests were of little diagnostic value except for the C. laboratory clue that confirms the suspicion of Q fever endocarditis. In our laboratory all but one patient who have ever shown a Phase I titre of 1:256 or greater have eventually been shown to have Q fever endocarditis. The one exception is still being followed. In the symptomatic stage only four patients with Q fever endocarditis had a Phase I antibody titre of less than 1:512 (one was 1:256 and three were 1:128).
In our laboratory, therefore, Phase I antibody titres of 1: 128 and above suggest the diagnosis. All patients with these levels are followed up carefully. Readings of 1:512 or greater are virtually diagnostic of the presence of Q fever endocarditis.
At least one of our patients had a known valvular lesion before his initial attack of Q fever and, in three others, the valvular lesion was known to be present long before the overt symptoms of Q fever endocarditis appeared. In seven patients the aortic valve was bicuspid, indicating a congenitally abnormal valve prior to the onset of the Q fever endocarditis. Four patients gave a history of recurrent rheumatic fever and in two others valve thickening, cusp fusion and valve calcification were compatible with rheumatic valve damage prior to the onset of Q fever endocarditis. While in some patients it was impossible to ascertain whether the valve was normal or abnormal prior to the onset of rickettsial endocarditis, in most patients it would appear that the infections occurred on a valve already damaged by rheumatic fever or on one which was congenitally abnormal.
In our experience, the appearance of the affected valve is typical. The valves are often calcified with small areas of necrotic, thrombotic vegetations. Ten of the 14 aortic valves with endocarditis, either operated on or seen at autopsy, showed aneurysms of the aortic wall at the base of the leaflet. Such aneurysms were particularly striking in case 9 and in the patient whose infection we considered to have been cured by therapy (case 10). These aneurysms are demonstrable angiographically and are helpful in establishing the diagnosis of Q fever endocarditis (fig. 4) .
The most useful drug in the treatment of Q fever endocarditis is tetracycline,7 and we have used 500 mg four times daily for some months, then 250 mg four times daily for a year or more. If oral therapy should cause side effects, parenteral pyrrolidino-methyl-tetracycline should be used, as in case 10. It seems probable that this patient's Q fever endocarditis was sterilized by tetracycline therapy. Clinical features for the diagnosis were present. Following therapy the antibody titres to Phase 1 antigen fell ( fig. 3) , and when he died three years later an aneurysm similar to those often seen with Q fever endocarditis was found but no C. burneti was isolated.
Trimethroprim with sulphamethoxazole has been suggested as an alternative treatment8 but we have no personal experience with its use.
An index of the success in controlling the Q fever infection is the behavior of the C.F. antibody to Phase I antigen. The falling titre following surgery and tetracycline therapy is illustrated by case 3 ( fig. 3) at the time when macroscopic and microscopic examination for Q fever infection was negative at the second operation.
Valve replacement is undertaken when, despite medical treatment, increasing symptoms and worsening hemodynamics occur. Ten such patients were submitted to surgery. In case 2, clinical mitral incompetence and increasing heart size were noted one year after the aortic valve replacement. The aortic valve replacement remained competent throughout. Whether the mitral valve lesion was related to Q fever endocarditis, or to dilatation of the left ventricle associated with coronary artery disease is not clear. Falling antibody titres to both Phase I and Phase 2 antigen suggests that the Q fever infection was controlled.
In case 12 the aortic valve was replaced but the presence of Q fever endocarditis was not recognized at first. Aortic incompetence developed due to technical factors, but after a course of tetracycline, at reoperation three months later no macroscopic or microscopic evidence of continuing Q fever infection was present. As in this case, in our experience, no prosthetic valve replacing a Q fever infected valve has been damaged by continuing Q fever infection, all patients of course being treated postoperatively with tetracycline.
